Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

The conclusion is that treating scalp AVF caused by hair transplantation with endovascular methods like coiling is safe and effective.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Pranlukast and mirabegron may work as new diabetes drugs.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Men's thigh hair grows longer and has a longer growth cycle than women's, but arm hair growth is similar between genders.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Method measures minoxidil in tablets accurately and easily.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Scientists developed a cheaper, but slower, method to measure minoxidil in hair loss treatments with high accuracy.

Combination therapy promotes better hair growth and density.

Hair transplantation with FUE is safe, effective, and better than FUT for male hair loss.

ALDOA levels drop in hair cells during hair loss.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The Third World Congress of the International Academy of Cosmetic Dermatology discussed various topics like hair disorders, skin conditions, wound healing, shampoo technology, acne treatment, and the use of lasers in dermatology.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.